Compare Shell PLC (SHEL) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Shell PLC vs Vir Biotechnology Inc. Common Stock — how do they compare? Shell PLC trades at $104.23 (market cap $294.95B), while Vir Biotechnology Inc. Common Stock trades at $10.38 (market cap $1.76B). The key difference: Shell PLC is far larger — about 167.6× Vir Biotechnology Inc. Common Stock's market cap, and Shell PLC pays a 3.02% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Shell PLC for 91 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| SHEL | VIR | |
|---|---|---|
Market Cap | $294.95B | $1.76B |
Volume | 6,021,309 | 2,764,948 |
Sector | Energy | Health |
52-Week High | $103.58 | $11.78 |
52-Week Low | $70.31 | $5.12 |
Typical Hold Time | 91 Days | 0 Days |
Enterprise Value | $336.65B | $1.32B |
Dividend Yield | 3.02% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Shell (SHEL) trades at $102.99, up 1.38% on the day, near its 52-week high. The stock shows strong technical momentum with bullish moving averages, though oscillators indicate overbought conditions. Fundamentally, the company delivered earnings beats in Q1 and Q2 2026, with a forward P/E of 11.39 suggesting reasonable valuation. Recent news highlights strategic LNG expansion, including the Phase 2 approval for LNG Canada, positioning Shell for long-term growth in global gas markets.
The outlook for Shell remains positive, supported by robust cash flows, strategic investments in LNG, and a favorable analyst consensus with 62% buy ratings. Key risks include exposure to volatile oil prices and execution challenges in major projects. The stock offers value through dividends and growth potential, but investors should monitor energy market dynamics and project timelines.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Shell PLC
Shell is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, it produced 1.7 million barrels of liquids and 8.7 billion cubic feet of natural gas per day. At year-end 2021, reserves stood at 9.2 billion barrels of oil equivalent, 50% of which consisted of liquids. Its production and reserves are in Europe, Asia, Oceania, Africa, and North and South America. The company operates refineries with capacity of 1.8 mmb/d located in the Americas, Asia, Africa, and Europe and sells 15 mtpa of chemicals. Its largest chemical plants, often integrated with its local refineries, are in Central Europe, China, Singapore, and North America.
Read more on SHEL →About Vir Biotechnology Inc. Common Stock
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →
